8-K: Beneficient Enters $62 Million Liquidity Deal with ff Venture Capital Funds

Beneficient has agreed to a liquidity financing transaction with three ff Venture Capital funds, potentially increasing its loan portfolio collateral by up to $121.5 million.

Summary

• Beneficient has entered into agreements to purchase alternative assets from three ff Venture Capital funds.
• In exchange, the funds will receive up to $62 million in stated value of Beneficient's Series B Resettable Convertible Preferred Stock.
• The preferred stock is convertible into Class A common stock at an initial price of $0.1313 per share, subject to monthly resets.
• The conversion price can adjust monthly based on the five-day trailing volume weighted average price of the Class A common stock, with a floor of 20-50% of the initial price and a ceiling of the initial price.
• The transaction also includes potential earnout payments to the sellers over a period of up to ten years, based on the performance of the acquired assets.
• The closing of the transaction is subject to shareholder approval and other customary conditions.
• If all limited partners of the ff Venture Capital funds participate, the transaction could increase Beneficient's loan portfolio collateral by up to $121.5 million.
• The acquired alternative assets will continue to be managed by ff Venture Capital LLC.

Sentiment

Score: 7

Explanation: The document presents a positive development for Beneficient, with a significant potential increase in loan portfolio collateral and a new partnership with a leading venture capital firm. However, the transaction is subject to shareholder approval and other risks, which temper the overall sentiment.

Positives

• The transaction provides Beneficient with a significant increase in loan portfolio collateral, potentially up to $121.5 million.
• The structure of the deal allows Beneficient to acquire alternative assets while providing liquidity to the funds' limited partners.
• The earnout structure aligns the interests of Beneficient and the sellers, incentivizing the performance of the acquired assets.
• The transaction demonstrates Beneficient's ability to provide flexible and customized liquidity solutions for general partners.
• The company can finance the transaction directly from its balance sheet, offering more flexibility.

Negatives

• The transaction is subject to shareholder approval, which introduces uncertainty.
• The conversion price of the preferred stock is subject to monthly resets, which could lead to dilution for existing shareholders.
• The earnout payments are contingent on the performance of the acquired assets, which introduces risk.
• The transaction is complex, involving multiple parties and agreements.

Risks

• The transaction is contingent on shareholder approval, which may not be obtained.
• Limited partner participation in the transaction is not guaranteed, which could reduce the potential increase in loan portfolio collateral.
• The value of the acquired alternative assets may fluctuate, impacting the earnout payments and the overall success of the transaction.
• If the Class A common stock is delisted, the holders of the preferred stock have the right to force a repurchase of their shares, which could impact Beneficient's cash flow.
• The monthly reset of the conversion price could lead to dilution for existing shareholders if the stock price declines.

Future Outlook

The transactions are expected to close in the third calendar quarter of 2024, subject to shareholder approval and other closing conditions. The company anticipates that this transaction will provide a new means of liquidity for valuable alternative assets.

Management Comments

• Brad Heppner, Chief Executive Officer and founder of Beneficient, stated that the transaction illustrates how the company can provide liquidity for alternative assets and enable general partners to retain a portion of the upside.
• John Frankel, Founding Partner of ff Venture Capital, expressed pleasure in offering this new liquidity solution to their limited partners.

Industry Context

This announcement reflects a growing trend of providing liquidity solutions for alternative asset holders, particularly in the private equity and venture capital space. Beneficient is positioning itself as a key player in this market by offering customized solutions and leveraging its balance sheet.

Comparison to Industry Standards

• The use of convertible preferred stock with a reset mechanism is a common structure in private financing transactions, providing flexibility for both the issuer and the investors.
• The earnout structure is also a standard practice in acquisitions of alternative assets, aligning the interests of the buyer and seller.
• The potential increase in loan portfolio collateral is significant and could position Beneficient as a leader in providing liquidity solutions for alternative assets.
• The transaction is similar to other deals where companies acquire alternative assets in exchange for equity and potential future payments based on performance, such as the acquisition of private equity stakes by publicly traded investment firms.

Stakeholder Impact

• Shareholders will need to approve the transaction, which could impact the share price.
• Employees may benefit from the company's growth and expansion.
• Customers (general partners and limited partners) will have access to new liquidity solutions.
• Suppliers and creditors may see increased business opportunities with Beneficient.

Next Steps

• Beneficient will file a preliminary proxy statement and a definitive proxy statement with the SEC.
• The company will seek shareholder approval for the transaction.
• The transaction is expected to close in the third calendar quarter of 2024, subject to the satisfaction of closing conditions.

Key Dates

Keywords

liquidity, alternative assets, preferred stock, convertible, earnouts, venture capital, financing, shareholder approval, loan portfolio, reset, conversion price